INS and metabolic dysfunction-associated steatotic liver disease: Since several established pathogenetic mechanisms (in particular insulin resistance, oxidative stress, and apoptosis) seem to be involved in NAFLD, a number of therapeutic agents targeting these mechanisms (Figure1) have been tested not only in animal models but also in human adults and in children.